TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Report & Forecast 2022-2028

Global and United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 14 October 2022
  • Pages :99
  • Formats:
  • Report Code:SMR-7437411
OfferClick for best price

Best Price: $3480

Nonsteroidal AntiInflammatory Drugs NSAIDs Market Size, Share 2022


Market Analysis and Insights: Global Nonsteroidal AntiInflammatory Drugs NSAIDs Market

The global Nonsteroidal AntiInflammatory Drugs NSAIDs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal AntiInflammatory Drugs NSAIDs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal AntiInflammatory Drugs NSAIDs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal AntiInflammatory Drugs NSAIDs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal AntiInflammatory Drugs NSAIDs market.

Global Nonsteroidal AntiInflammatory Drugs NSAIDs Scope and Market Size

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Paracetamol

Ibuprofen

Aspirin

Naproxen

Others

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Novartis

Pfizer

Boehringer Ingelheim

Teva Pharmaceutical

Hospira

Lonza Group

Mylan

Aurobindo Pharma

Dr. Reddy's Laboratories

Actavis

Wuxi Apptec

Zhejiang NHU

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Nonsteroidal AntiInflammatory Drugs NSAIDs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Nonsteroidal AntiInflammatory Drugs NSAIDs, with price, sales, revenue, and global market share of Nonsteroidal AntiInflammatory Drugs NSAIDs from 2019 to 2022.

Chapter 3, the Nonsteroidal AntiInflammatory Drugs NSAIDs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nonsteroidal AntiInflammatory Drugs NSAIDs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Nonsteroidal AntiInflammatory Drugs NSAIDs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Nonsteroidal AntiInflammatory Drugs NSAIDs.

Chapter 13, 14, and 15, to describe Nonsteroidal AntiInflammatory Drugs NSAIDs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Nonsteroidal AntiInflammatory Drugs NSAIDs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 99 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size for the Year 2017-2028
1.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size for the Year 2017-2028
1.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
1.4.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
1.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
1.4.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
1.4.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Type
2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Type
2.1.1 Paracetamol
2.1.2 Ibuprofen
2.1.3 Aspirin
2.1.4 Naproxen
2.1.5 Others
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017, 2022 & 2028)
2.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028)
2.4 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017, 2022 & 2028)
2.5 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028)
3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Application
3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017, 2022 & 2028)
3.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028)
3.4 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017, 2022 & 2028)
3.5 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028)
4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Competitor Landscape by Company
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Company
4.1.1 Top Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Ranked by Revenue (2021)
4.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Player (2017-2022)
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Concentration Ratio (CR)
4.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in 2021
4.2.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Headquarters, Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Headquarters and Area Served
4.3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Company
4.5.1 Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2020, 2021 & 2022)
5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2028)
5.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017-2022
5.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
6.1.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
6.3.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
6.4.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Details
7.1.2 Novartis Business Overview
7.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.1.5 Novartis Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Details
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.2.5 Pfizer Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Details
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.3.5 Boehringer Ingelheim Recent Development
7.4 Teva Pharmaceutical
7.4.1 Teva Pharmaceutical Company Details
7.4.2 Teva Pharmaceutical Business Overview
7.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.4.5 Teva Pharmaceutical Recent Development
7.5 Hospira
7.5.1 Hospira Company Details
7.5.2 Hospira Business Overview
7.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.5.5 Hospira Recent Development
7.6 Lonza Group
7.6.1 Lonza Group Company Details
7.6.2 Lonza Group Business Overview
7.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.6.5 Lonza Group Recent Development
7.7 Mylan
7.7.1 Mylan Company Details
7.7.2 Mylan Business Overview
7.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.7.5 Mylan Recent Development
7.8 Aurobindo Pharma
7.8.1 Aurobindo Pharma Company Details
7.8.2 Aurobindo Pharma Business Overview
7.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.8.5 Aurobindo Pharma Recent Development
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Company Details
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.9.5 Dr. Reddy's Laboratories Recent Development
7.10 Actavis
7.10.1 Actavis Company Details
7.10.2 Actavis Business Overview
7.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.10.5 Actavis Recent Development
7.11 Wuxi Apptec
7.11.1 Wuxi Apptec Company Details
7.11.2 Wuxi Apptec Business Overview
7.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.11.5 Wuxi Apptec Recent Development
7.12 Zhejiang NHU
7.12.1 Zhejiang NHU Company Details
7.12.2 Zhejiang NHU Business Overview
7.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
7.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
7.12.5 Zhejiang NHU Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 6. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Player, 2017-2022
Table 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
Table 15. Top Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Novartis Company Details
Table 31. Novartis Business Overview
Table 32. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 33. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 34. Novartis Recent Development
Table 35. Pfizer Company Details
Table 36. Pfizer Business Overview
Table 37. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 38. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 39. Pfizer Recent Development
Table 40. Boehringer Ingelheim Company Details
Table 41. Boehringer Ingelheim Business Overview
Table 42. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 43. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 44. Boehringer Ingelheim Recent Development
Table 45. Teva Pharmaceutical Company Details
Table 46. Teva Pharmaceutical Business Overview
Table 47. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 48. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 49. Teva Pharmaceutical Recent Development
Table 50. Hospira Company Details
Table 51. Hospira Business Overview
Table 52. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 53. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 54. Hospira Recent Development
Table 55. Lonza Group Company Details
Table 56. Lonza Group Business Overview
Table 57. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 58. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 59. Lonza Group Recent Development
Table 60. Mylan Company Details
Table 61. Mylan Business Overview
Table 62. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 63. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 64. Mylan Recent Development
Table 65. Aurobindo Pharma Company Details
Table 66. Aurobindo Pharma Business Overview
Table 67. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 68. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 69. Aurobindo Pharma Recent Development
Table 70. Dr. Reddy's Laboratories Company Details
Table 71. Dr. Reddy's Laboratories Business Overview
Table 72. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 73. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 74. Dr. Reddy's Laboratories Recent Development
Table 75. Actavis Company Details
Table 76. Actavis Business Overview
Table 77. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 78. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 79. Actavis Recent Development
Table 80. Wuxi Apptec Company Details
Table 81. Wuxi Apptec Business Overview
Table 82. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 83. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 84. Wuxi Apptec Recent Development
Table 85. Zhejiang NHU Company Details
Table 86. Zhejiang NHU Business Overview
Table 87. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 88. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 89. Zhejiang NHU Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Picture
Figure 2. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2028 (US$ Million)
Figure 4. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2028 (US$ Million)
Figure 6. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share in Global 2017-2028
Figure 7. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 8. Product Picture of Paracetamol
Figure 9. Product Picture of Ibuprofen
Figure 10. Product Picture of Aspirin
Figure 11. Product Picture of Naproxen
Figure 12. Product Picture of Others
Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type in 2022 & 2028
Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2017-2028)
Figure 16. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type in 2022 & 2028
Figure 17. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2017-2028)
Figure 19. Product Picture of Hospital Pharmacies
Figure 20. Product Picture of Retail Pharmacies
Figure 21. Product Picture of Online Pharmacies
Figure 22. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2022 & 2028
Figure 23. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2017-2028)
Figure 25. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2022 & 2028
Figure 26. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2017-2028)
Figure 28. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Novartis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 60. Hospira Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 61. Lonza Group Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 62. Mylan Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 63. Aurobindo Pharma Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 64. Dr. Reddy's Laboratories Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 65. Actavis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 66. Wuxi Apptec Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 67. Zhejiang NHU Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount